RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinomaSifan Yu(Peking University), Jun Guo(Peking University)Cell Death and DiseaseMarch 15, 201910.1038/s41419-019-1488-2Cited by 50SaveCiteExport RISWatch citationsRelated PapersPhosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma|BMC Cancer|2014|54First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors|British Journal of Cancer|2025|7